Full Text View
Tabular View
No Study Results Posted
Related Studies
Serotonin 1A Agonists and Cognition in Schizophrenia
This study has been completed.
Study NCT00178971   Information provided by Vanderbilt University

First Received on September 12, 2005.   Last Updated on January 6, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Additional conditions recognized in this trial
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
adjunctive treatment with buspirone
placebo
Additional drug interventions recognized in this trial
Buspirone
Serotonin
More general drug interventions related to this trial
Anti-Anxiety Agents
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Receptor Agonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Vanderbilt University
National Alliance for Research on Schizophrenia and Depression


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services